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RESEARCH ARTICLE
A Mycobacterium avium subsp. 
paratuberculosis relA deletion mutant 
and a 35 kDa major membrane protein elicit 
development of cytotoxic T lymphocytes 
with ability to kill intracellular bacteria
Gaber S. Abdellrazeq1,2, Mahmoud M. Elnaggar1,2, John P. Bannantine3, Kun T. Park4, Cleverson D. Souza5, 
Brian Backer6, Victoria Hulubei1, Lindsay M. Fry7, Samy A. Khaliel2, Helmy A. Torky2, David A. Schneider1,7 
and William C. Davis1*
Abstract 
Efforts to develop live attenuated vaccines against Mycobacterium avium subspecies paratuberculosis (Map), using 
indirect methods to screen Map deletion mutants for potential efficacy, have not been successful. A reduction in 
the capacity to survive in macrophages has not predicted the ability of mutants to survive in vivo. Previous studies 
for screening of three deletion mutants in cattle and goats revealed one mutant, with a deletion in relA (ΔMap/relA), 
could not establish a persistent infection. Further studies, using antigen presenting cells (APC), blood dendritic cells 
and monocyte derived DC, pulsed with ΔMap/relA or a 35 kDa Map membrane protein (MMP) revealed a component 
of the response to ΔMap/relA was directed towards MMP. As reported herein, we developed a bacterium viability 
assay and cell culture assays for analysis and evaluation of cytotoxic T cells generated against ΔMap/relA or MMP. 
Analysis of the effector activity of responding cells revealed the reason ΔMap/relA could not establish a persistent 
infection was that vaccination elicited development of cytotoxic CD8 T cells (CTL) with the capacity to kill intracellular 
bacteria. We demonstrated the same CTL response could be elicited with two rounds of antigenic stimulation of APC 
pulsed with ΔMap/relA or MMP ex vivo. Cytotoxicity was mediated through the perforin granzyme B pathway. Finally, 
cognate recognition of peptides presented in context of MHC I and II molecules to CD4 and CD8 T cells is required for 
development of CTL.
© The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Mycobacterium avium subspecies paratuberculosis 
(Map) is a pathogen with a broad host range. It is the 
causative agent of Johne’s disease (JD) in cattle, a major 
disease problem in the US and other countries [1]. 
Cumulative studies now show humans are susceptible to 
infection with Map. Studies have revealed some infected 
subjects develop clinical disease manifestations varying 
from an ileitis in humans referred to as Crohn’s disease, 
to other diseases associated with autoimmunity [2–5]. 
To reduce exposure of the public to Map, there is a need 
to find ways to clear dairy herds of Map. This has proven 
difficult, however, because efforts to date have not yielded 
a vaccine that elicits a protective immune response. This 
is attributable in part to the lack of methods to accurately 
predict the efficacy of candidate vaccines before testing 
in the field.
As illustrated by results from a standardized multi-
institutional vaccine study, the use of macrophages and 
mice as indirect approaches to screen a set of candidate 
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Map mutant vaccines for efficacy were not successful [6, 
7]. The conclusion drawn from the study suggested more 
direct methods are needed to fully evaluate the immune 
response to candidate vaccines in the natural host [7, 
8]. Many of the mutants submitted for evaluation in the 
study were excluded from a vaccine trial in the natural 
host because they did not exhibit efficacy in macrophage 
and mouse model systems [8]. This was the fate of the 
three mutants our group submitted for evaluation in the 
study. Studies in cattle and goats, however, had shown 
deletion of one gene, relA, interfered with the capacity 
of Map to establish a persistent infection, indicating the 
mutant was a good candidate for further evaluation [9]. 
An immune response to the mutant cleared infection 
and limited the capacity of wild type Map to establish an 
infection [10].
In light of the problems of using indirect methods of 
assessing the potential efficacy of candidate vaccines, 
we focused on development of methods to examine the 
immune response to candidate vaccines in the natural 
host. We developed an ex vivo platform to study the func-
tional activity of T lymphocytes proliferating in response 
to live-attenuated and peptide-based candidate vaccines. 
The first studies conducted with steers vaccinated with 
ΔMap/relA demonstrated a CD4 and CD8 T cell recall 
response could be elicited ex vivo from peripheral blood 
mononuclear cells (PBMC) stimulated with ΔMap/relA 
[9, 11]. Development of a monoclonal antibody (mAb) 
to CD209, uniquely expressed on blood APC, dendritic 
cells (bDC), monocyte derived dendritic cells (MoDC), 
and monocyte derived macrophages (MoMΦ), allowed 
us to extend the studies and characterize the response in 
greater detail using APC pulsed with Ag for Ag presenta-
tion to T cells [12]. Analysis revealed the recall response 
could be elicited by antigenic peptides presented by 
APC pulsed with ΔMap/relA. Presentation of antigens 
by APC was blocked by mAbs specific for MHC class I 
and II molecules showing the recall response was MHC 
restricted [12].
Further studies were conducted to dissect the recall 
response and determine which antigens were presented 
by the APC. This approach revealed a major component 
of the response was directed towards a 35 kDa membrane 
protein of Map, termed MMP [13]. The recall response 
to MMP was equivalent to the response elicited by 
ΔMap/relA [12]. As reported herein, further analysis of 
the immune response to ΔMap/relA and MMP required 
development of two assays: (1) a bacterium viability assay 
that was faster than the colony forming unit (CFU) assay 
for assessment of CTL activity against Map and (2) a 
method to characterize the functional activity of CD4 
and CD8 T cells ex  vivo. These newly developed assays 
demonstrated that vaccination with ΔMap/relA elicits 
the development of CTL with the ability to kill intracel-
lular bacteria. Further analysis revealed the CTL activity 
was directed towards MMP. Follow up studies with MMP, 
ex vivo, demonstrated the same CTL response could be 
elicited with APC from unvaccinated cattle pulsed with 
MMP. Analysis the CTL activity revealed cytotoxicity 




Eight Holstein steers were obtained from the Map free 
Washington State University (WSU) dairy herd from 
2013 to 2017. In the first phase of the study, two of the 
steers were vaccinated with the ΔMap/relA mutant and 
maintained as a source of blood to characterize cell 
responses elicited by ΔMap/relA and MMP. Two addi-
tional age-matched naïve steers were maintained as con-
trols. In the second phase of the study, four additional 
unvaccinated naïve steers were used as a source of blood 
to conduct the ex vivo studies on the immune response 
to ΔMap/relA and MMP. The vaccinated steers were kept 
in an open feed lot since initial studies demonstrated the 
mutant ΔMap/relA was immune eliminated and did not 
present a health risk to other cattle under study [9]. All 
the steers were maintained by the college staff. The steers 
were in good health during the studies. Midway through 
the initial studies, however, one of the vaccinated steers 
had to be euthanized because he was unruly and an 
injury risk to the staff. All protocols were approved by 
the WSU Institutional Animal Care and Use Committee 
(ASAFs 3360 and 04883).
Preparation of Map K10,  K10GFP, ΔMap/relA, and MMP
The ΔMap/relA mutant was constructed in the K-10 
and  K10GFP strains of Map using site directed allelic 
exchange, as previously described [14]. Cultures of Map 
K10,  K10GFP, and ΔMap/relA were prepared from single 
colonies and used to inoculate Middlebrook 7H9 broth 
flasks (Difco, BD biosciences, USA) supplemented with 
6.7% para-JEM GS (Trek Diagnostic Systems, OH, USA), 
2  μg/mL mycobactin J (Allied Monitor, MO, USA), and 
0.05% Tween 80 (Sigma-Aldrich Corp.) [9, 14]. The cul-
tures were expanded on a shaking stand at 37 °C. When 
the broth cultures reached an  OD600 of 0.6–0.8, master 
stocks were prepared in 1.5 mL micro-centrifuge screw-
cap tubes for immediate use in each experiment. To 
ensure a single-cell suspension, bacterial stocks were dis-
aggregated by passages through a 26-gauge needle three 
times, then the bacterial numbers were estimated based 
on the final  OD600 values [14].
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The full length MMP is encoded by MAP2121c in the 
K-10 genome [15]. It was expressed in ClearColi as a 
maltose-binding protein for purification [16].
Bacterium viability assay
The Map viability assay was adapted from a method 
developed by Kralik et al. [17] to distinguish and quantify 
the concentration of live Map present in food products 
and samples from the environment. The method involves 
the use of propidium monoazide (PMA), a membrane 
impermeant fluorescent compound similar to propidium 
iodide. It only enters dead cells and intercalates into DNA 
[18]. When it is activated by light, it binds covalently to 
DNA and blocks binding of probes used to detect Map 
genes. The concentration of live Map in a mixture of live 
and dead bacteria is determined from a standard curve 
generated with known concentrations of pure DNA from 
live Map. The number of live bacteria present in a sam-
ple preparation is determined by using quantitative PCR 
(qRT-PCR) with a probe specific for a single copy gene, 
F57, specific for Map [17]. Two types of controls were 
used to adapt the PMA method for measuring Map kill-
ing. The first set of controls was used to demonstrate the 
concentration of live Map in a defined mixture of live and 
dead bacteria, which was determined from a standard 
curve generated with DNA from a known number of live 
Map. The controls were prepared from pure DNA from 
live Map for use as reference standards for extrapolat-
ing the extent of killing mediated by Ag-specific CTL. In 
the first set of controls, tubes were prepared to contain 
2 × 107 Map/ tube. One set was heat-killed by incubat-
ing Map at 90 °C for 15 min. Tubes were then prepared 
to contain 100% live, 50% live/50% killed and 100% killed 
Map suspended in 400 μL of  H2O in 1.5 mL translucent 
Eppendorf tubes and stored at −20  °C until processed. 
The second set of controls was used to quantitate the 
number of live Map present in Map-infected MoMΦ 
(generation of MoMΦ described below). This set of con-
trols was essential for determining the extent of killing by 
CTLs since it covered the dynamic range for detection of 
live vs dead Map obtained from infected MoMΦ before 
and after incubation with CTL. Aliquots of Map mixed in 
four ratios, 100% live, 75% live/25% killed, 25% live/75% 
killed, and 100% killed, were prepared and added to the 
cultures of MoMΦ at a MOI of 10 respectively and incu-
bated for 3 h. The cultures were then washed to remove 
free bacteria. In this set of controls, cells were lysed fol-
lowing infection and incubation with Map by adding 
2  mL of 0.01% saponin in  H2O and incubating at 37  °C 
for 15 min. The cell lysates were centrifuged for 30 min 
at 4500 rpm to pellet the bacteria. The supernatants were 
discarded and the pellets re-suspended in 1  mL  H2O 
and transferred into micro-centrifuge tubes. The second 
centrifugation step was performed to harvest the washed 
bacteria at 14 000 rpm for 10 min. The supernatants were 
discarded, and the pellets re-suspended in 400 μL of  H2O 
in 1.5  mL translucent Eppendorf tubes and stored at 
−20 °C until used.
Treatment with PMA to block binding of the F57 probe
The basic procedure for PMA treatment was carried 
out according the manufacturer’s instructions. 1  µL of 
20 mM PMA working stock solution was added to 400 µL 
of the previously prepared preparations of cell controls to 
reach a final dye concentration of 50 µM. The translucent 
PMA-treated tubes were incubated at room temperature 
for 5 min in the dark on a rocker followed by brief spin-
ning. To avoid overheating during exposure to the halo-
gen light, a plastic tray was prepared with a frozen ice 
pack wrapped in aluminum foil. The tubes were placed in 
a diagonal slant position on top of the ice pack. The tray 
was then set on a rocking platform to ensure continuous 
mixing during light exposure. Light exposure was per-
formed for 5 min using a halogen lamp with a 650 W bulb 
placed at a distance of ~20 cm from the tubes. Cells were 
subsequently harvested by centrifugation at 10  000 ×  g 
for 5 min. The supernatants were discarded and the cell 
pellets from the two sets of controls processed for isola-
tion of DNA [19].
DNA extraction
DNA was extracted using the protocol for Gram-positive 
bacteria using  DNeasy® Blood and Tissue kit (Qiagen, 
USA) following enzymatic lysis to facilitate breakdown 
of the Map cell wall as described by Park et  al. [19]. In 
all cases, DNA extraction was performed in duplicate. 
The DNA was eluted in 100  μL of the designated elu-
tion buffer in the kits. DNA yield was measured by a 
 NanoDrop® ND-1000 Spectrophotometer (Thermo 
Fisher Scientific Inc., Waltham, USA) using  A260/280 ratio 
with 1 μL of sample.
Quantitative real‑time PCR
We used the TaqMan RT-PCR method, targeting the sin-
gle copy F57 gene specific for Map (F57 qPCR) to quan-
tify the relative concentration of live Map in all samples 
[20]. The StepOnePlus Real-Time PCR System machine 
(Applied Biosystems, CA, USA) was used to collect 
the data. Each DNA sample was diluted to 1 ng/μL and 
run in duplicate. The total reaction volume was 25  μL 
including 5  μL of the DNA sample. The qPCR condi-
tions and sequences for primer and probe were the same 
as previously described [19]. The reactions were run for 
40 cycles. Genomic DNA (gDNA) prepared from a pure 
culture of Map, was used to generate the standard curve 
using the F57 probe. Eight dilutions of DNA were used, 
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starting with 4 × 107 copies diluted down to 4 copies. The 
mass of one copy of Map gDNA was calculated using the 
following equation:
where n is the genomic size and m is the mass of the 
genome [19]. The qPCR results were analyzed using Ste-
pOne Software v2.1 (Applied Biosystems). A reduction in 
signal correlates with a reduction in the live Map present 
in a preparation of Map containing live and dead Map. 
The frequencies of viable Map present in the samples 
were determined based on the means of the threshold 
 (CT) values as described by Kralik et  al. [17].  CT values 
are inverse to the amount of amplified target gene in the 
tested sample (lower  CT values indicate a higher concen-
tration of the targeted gene and vice-versa).
Ex vivo assays to characterize the functional activity of CD4 
and CD8 T cells
The flow diagram in Figure 1 illustrates the ex vivo proto-
cols used to conduct the studies with cells obtained from 
the vaccinated and unvaccinated steers.
Generation of MoDC and CTL from PBMC 
from the vaccinated and unvaccinated control steers
As illustrated in Figure 1, the first blood draw from the 
vaccinated and unvaccinated control steers was used to 
generate MoDC for antigen (Ag) presentation to mono-
cyte depleted PBMC (mdPBMC). Magnetic microbeads 
coated with a cross-reactive anti-human CD14 mAb 
were used to isolate monocytes per the manufacturer’s 
instructions (Miltenyi Biotec) [21]. The average purity 
of isolated  CD14+ cells was greater than 98%, as deter-
mined by FC analysis using an anti-bovine CD14 mAb, 
CAM36A [11, 22]. Monocytes (2 × 106) were added to 
wells of six well culture plates and cultured in 3  mL of 
complete culture medium (cRPMI) [RPMI-1640 medium 
with GlutaMAX™ (Life Technologies, CA, USA) sup-
plemented with 10% calf bovine serum (CBS), 1  mM 
β-mercaptoethanol, 100  units/mL of penicillin G, and 
100 μg/mL of streptomycin sulfate] in the presence of a 
DC growth cocktail containing bovine GM-CSF and IL-4 
(Kingfisher Biotech, MN, USA). On the 3rd day, 1.4 mL of 
the medium was replaced with 1.8 mL of fresh medium 
containing the cocktail. The cultures were incubated 
for an additional 3  days to obtain MoDC. ΔMap/relA 
(5 × 106  Map/well) or MMP (5  μg/mL) were added to 
the cultures of MoDC and incubated for 3 h at 37 °C, 5% 
 CO2. The adherent MoDC were then carefully washed 3 
times with warm RPMI (without antibiotics) to remove 








Following preparation of fresh PBMC from the sec-
ond blood draw of the vaccinated and control steers, one 
portion was used to prepare monocyte depleted PBMC 
(mdPBMC), as described, using magnetic beads coated 
with anti-CD14 to remove monocytes. The mdPBMC, 
were added to their respective autologous MoDC 
pulsed with ΔMap/relA or MMP (2 × 106/mL in 5 mL of 
cRPMI). Following 6  days of culture, the cells were col-
lected and used in FC and the Map killing assay. The sec-
ond portion of fresh PBMC was used to generate MoMΦ 
as described below for use in the ex vivo studies.
Generation of MoDC and CTL from PBMC 
from the unvaccinated steers
Two rounds of antigenic stimulation were used to gener-
ate CTL from mdPBMC from the unvaccinated steers. 
The same general protocol was used as illustrated in Fig-
ure  1. The main difference is that the first blood draw 
from the unvaccinated steers was used for (1) the first 
round of stimulation of mdPBMC with ΔMap/relA and 
Figure 1 Protocol for testing activity of CD4, CD8 T cells 
stimulated with Ag‑pulsed bDC, MoDC. See “Materials and 
methods” for detail.
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MMP, processed and presented by bDC (present in the 
mdPBMC) and (2) to generate MoDC for use in the sec-
ond round of antigen (Ag) presentation to mdPBMC by 
MoDC pulsed with ΔMap/relA or MMP. The second 
blood draw was used to generate MoMΦ for use as target 
cells. The rest of the protocol was identical to the proto-
col described in Figure 1.
Generation of MoMΦ for use as target cells
At the times indicated in the protocol, fresh PBMC were 
re-suspended in cRPMI, placed in 150 mm tissue culture 
plates and incubated overnight. The majority of the non-
adherent cells were then removed the following day. The 
adherent cells were cultured in fresh medium for 4 days 
then brought into suspension by incubating them on ice 
in the presence of EDTA in PBS [4 mL EDTA (250 mM 
stock in  H2O), 5 mL CBS, 91 mL PBS]. The cells were re-
suspended in cRPMI, counted, and then used to prepare 
MoMΦ for scanning confocal microscopy or use in the 
viability assay.
Infection of MoMΦ with Map  K10GFP for scanning confocal 
microscopy
A two chamber culture slide was used to prepare cul-
tures of MoMΦ infected with Map  K10GFP to deter-
mine whether a 3  h incubation time is sufficient for 
preparing infected MoMΦ for use in the intracellular 
killing assay. MoMΦ were added to the two chambers 
(~2 × 104 MoMΦ/well) of the culture slide. After 2 days of 
additional culture, the MoMΦs were infected with  K10GFP 
at a MOI of 10:1 (2 × 105  K10GFP to ~2 × 104 MoMΦ) in 
antibiotic free cRPMI. The slide was incubated at 37  °C, 
5%  CO2 for 3  h. Immediately following incubation, the 
medium containing free bacteria was washed away with 
warm cRPMI. The cells were then treated with a saponin-
based permeabilization and wash reagent (BD Pharmin-
gen) for 30 min at room temperature, then washed once 
with 1  mL of PBS. The cells were counter stained for 
5  min with 500  µL of diluted (1:3000) propidium iodide 
stain (1 mg/mL stock solution, Invitrogen). Subsequently, 
the cells were rinsed several times in PBS then fixed with 
2% formaldehyde in PBS overnight at 4 °C. After fixation 
the cells were covered with Vectasheild antifade agent and 
imaged on a Leica SP8 scanning confocal microscope, 
using the Leica Application Suite X software 1.10.12420.
Infection of MoMΦ for use in the viability assay
MoMΦ were distributed into six well culture plates 
(2 × 106 cells/well) and cultured for an additional 2 days 
and then used as target cells.
MoMΦ were infected with Map at a multiplicity of 
infection (MOI) of 10:1 (2 × 107 Map to ~2 × 106 MoMΦ/
well) in antibiotic free cRPMI. The culture plates were 
centrifuged at 700 × g for 5 min, then incubated at 37 °C, 
5%  CO2 for 3 h. Extracellular bacteria were removed by 
washing 5 times with warm RPMI with no antibiotics. 
A vacuum source, equipped with a side-arm flask, rub-
ber tubing and a pipette tip, was used for liquid removal 
in culture wells to avoid detaching the adherent MoMΦ. 
Two wells from each of the respective sets of 6 wells, 
containing Map infected MoMΦ, were used as controls, 
without addition of primed or unprimed preparations of 
mdPBMC.
Incubation of mdPBMC from the vaccinated 
and the control steers with MoMΦ alone or infected 
with Map
mdPBMC prepared from the vaccinated and control 
steers as outlined in Figure  1, were added to the cul-
tures of MoMΦ alone or MoMΦ infected with Map 
(2 × 106  cells/well). After incubation for 6  h, the non-
adherent cells were washed away with warm RPMI. The 
remaining MoMΦ were collected and processed for the 
Map viability assay.
Incubation of mdPBMC from unvaccinated steers 
with MoMΦs, alone or infected with Map
mdPBMC preparations from the unvaccinated steers 
prepared according to the protocol, were added to the 
preparations of MoMΦ alone or infected with Map 
(2 × 106  cells/well) and incubated for 24  h. The non-
adherent cells were collected and held separately until 
collection of the adherent cells and then recombined for 
analysis of Map viability.
Cell processing for the Map viability assay
Cells in one control well of infected MoMΦ were lysed 
immediately following infection with Map using 0.01% 
saponin in  H2O as described. The pellets were re-sus-
pended in 400 μL of  H2O in 1.5 mL translucent Eppen-
dorf tubes and stored at −20  °C for later analysis. The 
other control well was incubated for 6 or 24 h concurrent 
with infected MoMΦ cultures overlaid with Ag-primed 
or unprimed preparations of mdPBMC. At the end of 
respective incubation times, all cultures were lysed as 
described. All lysed cells were treated with PMA and 
subjected to DNA extraction followed by qPCR as pre-
viously described in the viability assay to determine the 
extent of intracellular killing.
Intracellular labeling for perforin and GrzB
mdPBMC, prepared according the protocol (Figure  1) 
and co-cultured with Map-infected and non-infected 
MoMΦ for 24 h, were used to determine the frequency 
of CD4 and CD8 T cells positive for perforin and GnzB 
following incubation. In these sets of cells, Brefeldin A 
Page 6 of 16Abdellrazeq et al. Vet Res  (2018) 49:53 
(BFA; 1  μg/mL,  BD Biosciences) was added during the 
last 12 h of incubation to block secretion of proteins. The 
intracellular staining was carried out as described [23] 
with minor modification. In brief, the non-adherent cells 
were harvested and labeled for surface staining. Then, 
cells were fixed and permeabilized using BD Cytofix/
Cytoperm fixation permeabilization solution kit (BD Bio-
science) for 30 min in the dark on ice followed by wash-
ing in Perm/Wash buffer. The cells were re-suspended in 
Perm/Wash buffer and labeled intracellularly with dif-
ferent combinations of the mAbs shown in Table 1. Data 
were collected on a modified FACS Calibur DxP8 Ana-
lyzer equipped with a FlowJo operating system (Cytek 
Biosciences Inc. Fremont, CA, USA).
Apoptosis
Aliquots of Map infected MoMΦ incubated with Ag-
primed mdPBMC for 24  h were collected and used 
to examine the role of apoptosis in intracellular kill-
ing of Map, using a PE Annexin V Apoptosis kit (BD 
Pharmingen). [The kit includes Annexin V conjugated 
with phycoerythrin (PE) and 7AAD, a fluorescent 
membrane impermeant dye that is taken up by dead 
cells with a permeant membrane. Annexin V detects 
the changes in the membrane during the early stages 
of apoptosis. As apoptosis progresses with disruption 
in the integrity of the membrane, cells become double 
positive, necrotic]. Non-adherent cells comprised of 
lymphocytes and MoMΦ, from each culture were col-
lected and held in suspension. The adherent cells from 
each cell culture were suspended and added to the cor-
responding preparation of non-adherent cells. The cells 
were pelleted by low speed centrifugation and re-sus-
pended in PBS. Approximately 1 × 106 cells were trans-
ferred into 5 mL tubes and washed twice with cold PBS. 
Cells were then labeled according to the manufacturer’s 
instructions. Two types of controls were included in 
this assay (1) uninfected MoMΦ alone and (2) unin-
fected MoMΦ incubated with MMP-primed mdPBMC. 
The cell preparations were analyzed by FC within 1  h 
of labeling by gating only on MoMΦ. At least  105 gated 
events were collected for each cell preparation.
One set of the cultures used for the apoptosis study, 
as described above, was maintained for 3  days after 
initiation of co-culture of mdPBMC, to determine 
whether necrosis or apoptosis increased over time.
Flow cytometry (FC)
Cells, prepared for FC analysis at the times indicated in 
the protocol (Figure 1), were washed one time in PBS/
ACD, centrifuged, then re-suspended in serum-free 
RPMI and counted. For cell labeling, cells were dis-
tributed in 96 well polystyrene V-shape bottom micro-
plates  (106 cells/well). Combinations of mAbs (Table 1), 
obtained from the WSU Monoclonal Antibody Center 
(WSUMAC), were used for labeling as previously 
described [24]. Data were collected on a FACSort 
(BD Immunocytometry systems, San Jose, CA, USA) 
equipped with Cell Quest software. The gating strategy 
used to collect the data is shown in Figure 2.
Statistical analysis
Data were imported into JMP software (version 12.0.1; 
SAS Institute Inc., Cary, NC, USA) for statistical analy-
sis and graphical presentation (means and standard 
deviations). Two-way ANOVA was used to conduct 
statistical analyses and included an interaction term 
expect for the analysis of data represented in Figure 6B. 
In this instance, the second factor (blood donor) was 
instead considered a blocking factor. Post-hoc multiple 
comparisons were conducted using Tukey HSD (overall 
α = 0.05).
Table 1 MAbs used in the present study 
mAb Isotype Specificity/source Fluorochrome Labeling
ILA11A IgG2a CD4 WSUMAC PE CY5.5 Indirect
CACT138A IgG1 CD4 WSUMAC Alexa  Fluor® 647 Indirect
7C2B IgG2a CD8 WSUMAC PE CY5.5 Indirect
CACT80C IgG1 CD8 WSUMAC Alexa  Fluor® 647 Indirect
ILA116A IgG3 CD45R0 WSUMAC Alexa  Fluor® 488; PE Indirect
CAM36A IgG1 CD14 WSUMAC Alexa  Fluor® 647 Indirect
209MD26A IgG2a CD209 WSUMAC PE CY5.5 Indirect
δG9 IgG2b Perforin Biolegend PE Direct
B-D48 IgG1 Perforin Biolegend PE/CY7 Direct
351927 IgG2a Granzyme B R&D Systems PE Direct
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Results
Development of a PMA‑based viability assay to quantify 
the relative concentration of live Map in a mixed 
population of live and dead bacteria
Evidence obtained in previous studies designed to study 
the effector T cell response to Mycobacterium tuberculo-
sis (Mtb), used the CFU method to assess survival of bac-
teria [25, 26]. The lengthy process of CFU determination 
did not provide opportunity to examine effector T cell 
activity in detail. However, the novel immune cell overlay 
model designed to examine the effector T cell response to 
BCG infected MoMΦ, provided a method to examine the 
effector T cell recall response elicited from APC pulsed 
with Ags. To overcome the time required to determine 
viability by the CFU method, we adapted the method by 
Kralik et  al. [17] as an expedient alternative way to dis-
tinguish live from dead Map. This approach, which com-
bined a membrane impermeant fluorescent dye (PMA) 
with quantitative PCR, eliminated the need to determine 
CFU counts for quantifying Map in samples obtained 
from food and the environment [17, 27, 28]. Initial stud-
ies were conducted to determine whether this PMA 
method could be adapted for use in the present study. 
As illustrated in Figure 3, we verified it is possible to use 
qPCR with a single copy of the Map specific gene, F57, as 
a probe to generate a curve with a large dynamic range 
(4 × 107  copies of F57 to 4 copies). We then conducted 
studies to determine if there was sufficient resolution 
to distinguish differences in the relative percent of live 
bacteria in preparations of Map containing known pro-
portions of live and dead bacteria, starting with DNA iso-
lated from pure cultures of Map (Figure 3A). There was a 
background showing the PMA didn’t block all the DNA 
from dead bacteria. However, the mixtures of live and 
dead bacteria fit on the curve, with sufficient difference in 
 CT values between dead and live bacteria to distinguish 
and enumerate differences in the percent of live bacteria 
present in a mixture of dead and live bacteria. Map DNA 
isolated from infected MoMΦ also fit on the standard 
curve, but shifted values toward fewer copies of F57 and 
higher  CT values (Figure 3A).
We next determined if a sufficient number of bacte-
ria were taken up by MoMΦ in a 3  h time frame to be 
quantitated using the PMA method. A two well culture 
slide was prepared with MoMΦ and infected with Map 
 K10GFP under the same culture conditions used to set up 
infected MoMΦ for the viability assay (see "Materials and 
methods"). Confocal microscopy showed efficient bacte-
rial uptake following 3 h of incubation (Figure 3B), even 
without a centrifugation step to concentrate the bacteria 
to the cell surface of MoMΦ for uptake.
The qPCR assay showed the number of bacteria taken up 
was sufficient to consistently determine the relative percent 
of live Map present within MoMΦ after 3 h of incubation 
(Figure 3D). Importantly, the study showed there was mini-





















Figure 2 Flow cytometric gating strategy for analysis CD4, CD8 T cell response to Ag‑pulsed bDC/MoDC. Gates were placed to define small 
lymphocytes (G1) and large activated lymphocytes (G2) and color coded blue to track activated lymphocytes. A third gate was placed on CD4 cells 
in this illustration to isolate activated cells for analysis. Visualization in forward scatter (FSC) vs CD45R0 (memory) shows activated cells that increase 
in size appear in G2. A mdPBMC cultured in medium alone for 6 days. B mdPBMC following Ag stimulation and culture for 6 days. Comparison of 
cells in A with B show only Ag specific CD4 memory T cells proliferated in response to stimulation with MMP. This population also expressed CD25, 
an indication of cells in this gate are activated (not shown). Only the activated proliferating cells in the upper right quadrant were selected for data 
analysis. Gated CD8 T cells had equivalent profiles.
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incubation period with MoMΦ cultured alone or in the 
presence of mdPBMC from control steers. (Figure 3D). We 
concluded that the dynamic range between live and dead 
bacteria isolated from MoMΦ was adequate for studying 
the intracellular killing activity of effector CD4 and CD8 T 
cells proliferating in response to stimulation with MoDC, 
pulsed with ΔMap/relA or MMP.
Analysis of the proliferative response and functional 
activity of mdPBMC from the vaccinated and control steers 
stimulated by MoDC pulsed with ΔMap/relA or MMP
As reported previously, extensive studies with PBMC 
from the vaccinated steers showed a CD4 CD8 T cell 
recall response could be elicited ex  vivo by stimulation 
with ΔMap/relA [11, 12]. The studies demonstrated 
an equivalent recall response could be elicited with 
mdPBMC using bDC or MoDC pulsed with ΔMap/relA 
or MMP. The response was MHC restricted [12]. As 
reported here, studies were extended to determine if 
the functional activity of the proliferating cells could be 
determined using a modification of the intracellular kill-
ing assay described by Worku and Hoft [25] and a PMA-
based method to distinguish live from dead Map present 
in Map-infected MoMΦ [17].
We first examined the effector T cell recall response to 
MoDC pulsed with ΔMap/relA and MMP (Figure 4). The 
Figure 3 Killing assay. A Standard curve with 8 dilutions DNA from live Map (red boxes) 4 × 107 to 4 copies. Blue square data points represent 
DNA from two sets of controls; the lower set of squares are from Map DNA (2 × 107 Map) prepared from mixtures of 100% live, 50% live/50% dead, 
and 100% dead bacteria after PMA treatment. Upper four squares are from DNA isolated from Map after 3 h incubation with MoMΦ. Squares 
represent mixtures of Map used to infect MoMΦ, prepared at 2 × 107 Map: 100% live, 75% live 25% dead, 25% live 75% dead and 100% dead 
Map.  CT values represent average of duplicate preparations of DNA. B Confocal microscopy showing abundance of  K10GFP taken up during 3 h 
incubation with MoMΦ. C Killing by effector cells plotted on standard curve from A.  CT values of mdPBMC from vaccinated steer with MoDC-pulsed 
ΔMap/relA (a: gold box) or MMP (b: green box) and mdPBMC from one control steer stimulated with MoDC pulsed with ΔMap/relA (c: yellow box) 
or MMP (d: gray box). D Summary of 6 replications of killing assay comparing killing activity mdPBMC from vaccinated and control steers. Mean 
and standard deviation for each treatment effect (n = 6 independent experiments). Two-way ANOVA was significant (F = 88.3205; P < 0.0001) and 
included significant interaction effect between treatments and steer-status (F = 46.1411; P < 0.0001). Within unvaccinated steer S1 and vaccinated 
steer S3, mean effects of T6-∆Map/relA and T6-MMP were significantly greater than T6-control (each, P < 0.0001; ***S1 not shown). Mean effects 
within unvaccinated steer S2 either smaller (T6-∆Map/relA, P = 0.0027; *not shown) or not different (T6-MMP; P = 0.3668) than T6-control. Effect of 
T6-∆Map/relA or T6-MMP for vaccinated steer S3 was significantly greater than effect for either unvaccinated steer (each, P < 0.0001).
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proliferative responses to ΔMap/relA and MMP were 
very similar. We used Map infected-MoMΦ as targets 
for the study. The preliminary studies revealed effector 
T cells from the vaccinated steer were able to kill intra-
cellular bacteria whereas there was little killing activ-
ity observed with cells from the control steers (data not 
shown). Further testing with MoDC pulsed with MMP 
yielded similar results (data not shown). To complete and 
validate the observations, the entire protocol (outlined 
in the protocol, Figure 1) was repeated 6 times in paral-
lel with MoDC pulsed with ΔMap/relA in one set and a 
second set pulsed with MMP (Figure  3D). As observed 
in the preliminary studies to set up the assay, there was 
limited intracellular killing by effector cells from the con-
trol steer mdPBMCs stimulated once with MoDC pulsed 
with ΔMap/relA or MMP (Figures 3C and D). The rela-
tive concentration of live bacteria detected in infected 
MoMΦ incubated with unstimulated mdPBMC from the 
control steers was similar to the concentration present in 
infected MoMΦ incubated alone (Figure 3A). In contrast, 
few viable Map were present in infected MoMΦ incu-
bated with Ag-primed mdPBMC from the vaccinated 
steer. The repeat of the assay 6 times for both ΔMap/relA 
and MMP, demonstrated the consistency in results from 
test to test as summarized in Figure 3D (P < 0.0001).
Analysis of the proliferative and functional activity of naïve 
mdPBMC from unvaccinated steers stimulated with bDC 
and MoDC pulsed with ΔMap/relA and MMP
The question of why the ΔMap/relA mutant could not 
establish a persistent infection was answered [10]. Vacci-
nation elicited a CTL response that cleared the infection 
with ΔMap/relA. The ex vivo findings indicated that the 
effector activity of CD4 and CD8 T cells from the vacci-
nated steer, proliferating in response to stimulation with 
APC pulsed Map/relA and MMP, was directed towards 
MMP (Figures  3 and 4). To extend these findings, we 
conducted follow up studies entirely ex vivo. If success-
ful, we postulated this would afford a way to study the 
activity of APC at the time of Ag presentation and also 
responses of CD4 and CD8 T cells, differentiating in 
response to signaling by APC pulsed with Ags. As men-
tioned in the methods, we modified the stimulation pro-
tocol to include two rounds of stimulation of mdPBMC 
from the four unvaccinated steers, starting with stimulat-
ing mdPBMC with bDC pulsed with ΔMap/relA or MMP 
(first round of stimulation) and 6  days later stimulation 
with MoDC pulsed with ΔMap/relA or MMP (second 
round of stimulation). Comparison of the proliferative 
response to ΔMap/relA and MMP showed the responses 
were equivalent (data not shown). Based on these obser-
vations, further studies were conducted just with MMP. 
We repeated the complete protocol with the four steers. 
As shown in Figures  5A  and B, a proliferative CD4 and 
CD8 T cell response to MMP was evident by 6  days. 
However, cell proliferation was not sufficient for analy-
sis of CTL activity. There were not enough activated cells 
present after one round of stimulation to accurately per-
form the killing assay. After a second round of stimula-
tion, there was robust proliferation of both CD4 and CD8 
T cells, providing enough cells to perform the CTL assay 
(Figures 5C, 6A and B). 
The essential need for CD4 and CD8 T cell cognate 
recognition of MMP peptides presented by APC 
for development of CD8 CTL against Map
All the previous studies up to this time were conducted 
with mdPBMC because it was unknown whether the 
response to Ag peptides, processed and presented by 
APC pulsed with ΔMap/relA or MMP, required cognate 
recognition of Ag peptides by CD4 and CD8 T cells to 
generate CTL activity. Also, it was assumed but not veri-
fied that CTL activity was primarily associated with CD8 
T cells. To address these unknowns, a series of experi-
ments were conducted with freshly isolated mdPBMC 
from the 2 steers. The first experiments focused on deter-
mining whether both CD4 and CD8 T cells needed to be 






















Figure 4 Two‑way ANOVA comparison CD4, CD8 T cell 
response unvaccinated and vaccinated steers to Ag‑pulsed 
MoDC. The factors were steer-status (three levels: S1-unvaccinated, 
S2-vaccinated, S3-vaccinated) and treatments (four levels: D0, 
Control, ∆Map/relA, MMP). Tukey HSD (overall α = 0.05) was applied 
post-hoc to determine the statistical significance of comparisons of 
interest. For each T cell type (CD4 and CD8), the mean and standard 
deviation for each treatment effect (n = 6 independent experiments) 
within each steer-status is shown. The two-way ANOVAs for CD4 and 
CD8 T cells were significant (FCD4 = 158.2463, FCD8 = 379.0110; each, 
P < 0.0001) and each included a significant interaction effect between 
treatments and steer-status (FCD4 = 56.3527, FCD8 = ;165.4418; 
each, P < 0.0001). For both CD4 and CD8 T cells, the mean effects 
of ∆Map/relA and MMP in vaccinated steer S3 were greater than 
in unvaccinated steers S1 and S2 (each, P < 0.0001); significant 
differences not detected between unvaccinated steers in the 
mean effects of ∆Map/relA (PCD4 = 1.0000, PCD8 = 1.0000) or MMP 
(PCD4 = 0.9997, PCD8 = 1.0000).
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activity. The second set of experiments were focused 
on demonstrating whether CTL activity was primarily 
associated with CD8 T cells proliferating in response to 
Ag presented by APC. mdPBMC from 2 of the unvac-
cinated steers were depleted of either CD4 or CD8 T 
cells and then subjected to 2 rounds of stimulation with 
APC pulsed with MMP. Preparations of unseparated 
mdPBMC, unstimulated and stimulated, were used as 
controls. There was limited cell proliferation in cultures 
of mdPBMC depleted of CD4 or CD8 T cell following 
two rounds of stimulation with APC pulsed with MMP 
(data not shown). In contrast, there was robust prolifera-
tion of CD4 and CD8 T cells in the unseparated prepa-
rations of mdPBMC following two rounds of stimulation 
(results similar to those shown in Figure  5C). Follow-
ing demonstration that both CD4 and CD8 T cells must 
be present for generation of a proliferative and CTL 
response to MMP, we used the two steers to determine 
which cell subset(s) possessed CTL activity. Negative and 
positive selection were used to obtain preparations of Ag-
primed mdPBMC containing CD4 and CD8 T cells, CD4 
T cells, CD8 T cells alone or only γδ T cells. Preparations 
of unseparated unstimulated and stimulated mdPBMC 
were used as controls. The proliferation (not shown) and 
killing activity of unseparated preparations mdPBMC 
stimulated with APC, pulsed with MMP, were similar to 
the results obtained with all 4 steers (compare Figure 6C 
with Figure 6B). Killing activity was less but clearly evi-
dent in cell preparations containing both CD4 and CD8 
T cells and CD8 T cells alone (Figure 6C). Little or very 
limited killing activity was evident in cell preparations 
containing CD4 T cells. No killing activity was evident in 
the cell preparations containing γδ T cells (Figure 6C).
Role of the perforin/ GnzB pathway in intracellular killing 
of Map
Extensive studies have shown intracellular killing of 
intracellular bacteria and protozoan parasites is medi-
ated by perforin, Gnz B, and granulysin [29, 30]. We 
were interested in determining whether perforin and 
granzyme B were also involved in the intracellular kill-
ing of Map. A mAb reactive with bovine granulysin was 
not available. Nonetheless, we verified a mAb to human 
perforin (δG9) identified a conserved epitope on bovine 
perforin (data not shown) [31]. Screening of other com-
mercially available mAbs for cross reactivity with bovine 
perforin revealed B-D48, a mAb that recognizes a differ-
ent conserved epitope expressed on the native and newly 
synthesized forms of perforin, reacted with bovine per-
forin [32, 33]. This mAb was selected for further analysis 
to determine the pattern of expression of newly synthe-
sized perforin in CD4 and CD8 T cells at the end of the 
killing assay. In addition, a recent report showed a mAb 
to human GrzB, 351927, cross reacted with bovine GrzB 
[34]. We verified the mAbs cross-reactivity with bovine 
GrzB and then used it in the present study. The primed 
CTL were incubated with uninfected and infected 


















































Figure 5 Comparison response CD4, CD8 T cells from unvaccinated steers stimulated with MMP‑pulsed bDC and MoDC. A Representative 
flow cytometric profiles showing level of CD4 T cell proliferation following one and two rounds of antigenic stimulation by Ag-pulsed DC. B 
Representative flow cytometric profiles showing level of CD8 T cell proliferation following one and two rounds of antigenic stimulation by 
Ag-pulsed DC. C Two-way ANOVA with interaction. The factors were type of T cell (two levels: CD4, CD8) and MMP-stimulation (two levels: control, 
MMP). Tukey HSD (overall α = 0.05) was applied post-hoc to determine the statistical significance of comparisons of interest. The mean and standard 
deviation for each treatment effect for each type of T cell is shown (n = 4 unvaccinated steers). The two-way ANOVA was significant (F = 732.6776; 
P < 0.0001). The mean effect of MMP stimulation was significant (Fstimulation = 2188.613, P < 0.0001) but not dependent on T cell type (Finteraction = 1.33; 
P = 0.2092). The mean effect of T cell type was small but significant (CD4 effect estimate = 1.55 ± 0.56; FCD = 7.6591, P = 0.0170).
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necessary to stimulate synthesis of new perforin (Fig-
ure  7A). Newly synthesized perforin was only detected 
in memory CD4 and CD8 T cells stimulated with MMP-
pulsed MoDC, with the highest level of expression was 
in CD8 T cells (Figure 7A). Comparison of expression of 
GnzB showed expression was low in activated memory 
CD4 T cells and high in half the activated memory CD8 
T cells (Figure 7B).
Infected cells do not undergo apoptosis 
during intracellular killing of Map
Studies of the events associated with killing target cells 
by CTL have shown that introduction of GrzB into the 
cytoplasm of tumor cells or target cells infected with 
virus activates caspases that initiate apoptosis and cell 
death [35, 36]. The role of apoptosis in the intracellular 
killing of bacteria, however, has remained unresolved. 
Previous studies of intracellular killing of Mtb by 
Thoma-Uzynski et  al. [37] showed “host cell apoptosis 
is neither sufficient nor necessary for  CD8+ CTL to kill 
intracellular Mtb” [37]. We used a FC assay to deter-
mine if apoptosis is associated with intracellular kill-
ing of Map. Comparison of the frequency of necrotic 
apoptotic cells in preparations of infected MoMΦ incu-
bated alone vs necrotic apoptotic cells in preparations 
of uninfected MoMΦ incubated with primed mdPBMC 
showed the frequencies were similar and low. The fre-
quency was a little higher in preparations of infected 
MoMΦ incubated with primed mdPBMC (Figure  8). 
However, the majority of infected MoMΦ, incubated 
under the different conditions, were not necrotic or 
apoptotic even after 24  h of incubation. Most of the 
cells had intact membranes as detected with 7-AAD. 
An additional experiment with infected MoMΦ 
Figure 6 Comparison of the killing activity of CD4, CD8, and γδ T cells. A Representative set of results illustrated with the  CT values obtained 
with unseparated cell populations. The  CT values represent the average of duplicate preparations of DNA run at the same time. B A two-way 
ANOVA for the effect of mdPBMC stimulation (two levels: control, MMP), reponses grouped by unvaccinated steers (n = 4). The mean and standard 
deviation for each stimulation level (control, MMP) of mdPBMC from four unvaccinated steers. The effect of MMP stimulation was significant 
(Fstimulation = 130.4208; P = 0.0014). C No statistics were applied since only two of the four unvaccinated steers were used to obtain data on separated 
cell subsets.


























































Figure 7 Flow cytometric analysis showing expression of newly synthesized perforin, GnzB in CD4, CD8 T cells. A Newly synthesized 
perforin was highly expressed in CD8 T cells from unvaccinated steers with low expression in CD4 T cells (right set of graphs). Newly synthesized 
perforin was below the limits of detection in primed mdPBMC incubated with uninfected MoMΦ (center set of graphs). B Expression of GnzB in 



























Figure 8 Comparison of apoptosis in uninfected and infected MoMΦ incubated with MMP‑stimulated mdPBMC. The frequency of 
apoptosis was low in infected MoMΦ incubated with naïve unprimed mdPBMC and in uninfected MoMΦ incubated with MMP-stimulated 
mdPBMC. Although a small increase in apoptosis was observed in infected MoMΦ incubated with MMP-stimulated mdPBMC, the majority of cells in 
each cell preparation were neither necrotic nor apoptotic.
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incubated for 3  days with primed mdPBMC showed 
the majority of infected MoMΦ were still alive after the 
intracellular killing event.
Discussion
The studies presented here were focused on analysis of 
the immune response to Map using the natural host. The 
initial studies leading up to the present studies showed 
all animals exposed to Map under experimental condi-
tions at birth, develop an infection that elicits an immune 
response that controls but doesn’t eliminate the patho-
gen [38, 39]. Flow cytometric analysis of the immune 
response to Map and soluble Map Ags ex  vivo demon-
strated an immune response to Map could be detected 
3–5  months post exposure that included CD4 and 
CD8 T cells [39]. γδ T cells did not exhibit an Ag spe-
cific response. Further analysis with a cannulated ileum 
model demonstrated that Map introduced directly into 
the ileum are rapidly taken up and disseminated to other 
sites without establishing detectable lesions in the ileum 
containing Map, as detected by biopsy. In fact, no lesions 
were detectable up to 18  months post exposure [24]. A 
follow up study comparing the immune response to 
human and bovine isolates of Map showed no difference 
in the immune response to Map. The one interesting 
comparative observation was that it appeared the CD8 
T cell response in experimentally infected calves was 
delayed, reaching a maximum at 12 months [40]. Devel-
opment of a method to use site directed mutagenesis 
provided opportunity to look at the immune response to 
Map in greater detail and determine if any gene product 
was essential for establishing a persistent infection. Three 
genes were selected for analysis: relA, demonstrated 
to impair survival of Mtb in a mouse model [41]; pknG, 
shown to affect survival of BCG in macrophages [42]; 
and lsr2, shown to be involved in mediating multi-drug 
resistance to antibiotics [43]. In  vivo studies revealed, 
similar to the studies in mice with Mtb, that deletion of 
relA impaired survival [9, 10]. Comparison of survival 
with Map at necropsy showed wild type Map was readily 
detected in multiple tissues whereas ΔMap/relA was not 
detected in any tissue using culture and PCR. These find-
ings and the ex  vivo studies indicated there was a clear 
difference in the immune response to the ΔMap/relA 
mutant and suggested that deletion of the gene allowed 
for the development of an effector T cell response that 
cleared the infection. To investigate the immunological 
mechanisms accounting for clearance of the mutant, two 
steers were vaccinated with ΔMap/relA and maintained 
as a source of cells to characterize the effector T cells 
ex  vivo. We hypothesized the difference in the immune 
response to Map and ΔMap/relA might involve signal-
ing mediated through antigen presenting cells (APC). 
To examine this possibility we developed and used a 
mAb to CD209 (uniquely expressed on bDC, MoDC, 
and MoMΦ) to phenotypically identify and compare 
the capacity of bDC, MoDC, and MoMΦ to process and 
present Ags to effector memory T cells, elicited by vac-
cination with ΔMap/relA [12]. The studies revealed the 
complexity of the immune response to the mutant. The 
study revealed bDC, MoDC, and MoMΦ were essentially 
equal in their capacity to process and present Ag to naïve 
T cells. Of special interest, all three APCs presented anti-
genic peptides in context of MHC I and II molecules 
simultaneously and provided signaling that elicited a 
CD4 and CD8 proliferative response.
Ancillary studies conducted to determine which Map 
proteins might be involved in the immune response to 
Map, included examining the proliferative response 
to the whole and truncated forms of the 35  kDa mem-
brane protein, MMP [13, 44]. A proliferative response 
was obtained with the whole and truncated forms of the 
protein (unpublished). As reported here, further studies 
conducted to determine if MMP was a component of the 
recall response, elicited with ΔMap/relA, demonstrated it 
was included as a component of the immune response. 
Comparative studies demonstrated equivalent recall 
responses were obtained with ΔMap/relA and MMP 
with all three APCs [12]. The recall response was MHC 
restricted [12].
In the present study, we initially used the vaccinated 
and control unvaccinated steers to examine the func-
tional activity of memory T cells proliferating in response 
to Ag presentation by MoDC pulsed with ΔMap/relA 
and MMP. To conduct these studies, a viability assay 
was developed based on studies by Worku and Hoft, 
using patients with tuberculosis and control subjects 
vaccinated with the BCG [25]. In addition, we adapted 
an expedient method for distinguishing live from dead 
bacteria to obviate the problem of using CFU as a read 
out of bacterial viability [17]. Although the conditions 
for blocking all gene sites was not optimal for PMA, it 
was sufficient to be able to detect differences in live vs 
dead bacteria. The scale showed where the residual DNA 
from dead cells falls on the curve. The wide dynamic 
range between live and dead cells was consistent for 
distinguishing between DNA from live and dead bacte-
ria. Comparison of the recall and functional activity of 
memory CD4 and CD8 T cells proliferating in response 
to Ag presentation by MoDC pulsed with ΔMap/relA 
and MMP revealed equivalent CTL activity was elicited 
with ΔMap/relA and MMP. The results proved highly 
reproducible using APC pulsed with either ΔMap/relA 
or MMP. A singular observation made throughout the 
studies was, regardless of the route of exposure to Map, 
ΔMap/reA, or MMP, exposure resulted in development 
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of a CD4 CD8 T cell response [9, 12, 39, 40]. This raised 
two questions. Is cognate recognition of Ags by CD4 and 
CD8 a requirement for development of CTL activity? 
And, do both CD4 and CD8 T cells develop CTL activity? 
Only one of these questions could be answered with fur-
ther studies using vaccinated animals. This prompted us 
to explore the possibility of developing an assay to study 
the full CTL response ex vivo. The results showed equiv-
alent Ag presentation could be achieved with bDC and 
MoDC pulsed with either ΔMap/reA, or MMP. This sug-
gested APC could be used to develop a method to study 
the full immune response to Ags ex vivo. If successful, it 
would be possible to study mechanisms of Ag processing 
and presentation by APC to a relevant pathogen. It would 
also make it possible to study the importance of cognate 
recognition of antigenic peptides presented in context 
of MHC class I and II molecules in development of CTL 
activity.
As reported here, four unvaccinated steers were used 
to modify the protocol for studying the recall response 
starting with stimulation of naïve T cells with bDC 
pulsed with ΔMap/relA or MMP followed by a second 
round of stimulation with MoDC pulsed with ΔMap/relA 
or MMP. After demonstrating equivalent responses 
occurred with ΔMap/relA and MMP, further stud-
ies were focused on analysis of the immune response 
to MMP. The first question of interest was whether the 
CD4 and CD8 T cells needed to be present in a culture 
to generate CTL. The studies conducted to this point in 
the investigation involved use of mdPBMC. Little or no 
response was observed if CD4 and CD8 T cells were sep-
arated from preparations of mdPBMC before primary Ag 
presentation by bDC followed by secondary stimulation 
with MoDC. In contrast, a full CTL response was con-
sistently obtained if unseparated mdPBMC were used. 
The second question of interest was which T cell subset 
possessed the CTL activity. The unproven supposition 
was that CTL activity was primarily attributable to CD8 
T cells. To answer this question, mdPBMC primed with 
APC pulsed with MMP, were separated into 4 popula-
tions before incubating with infected MoMΦ target cells. 
Cell preparations containing CD4, CD8, and CD4/CD8 
were obtained by negative selection. The cell preparation 
containing  CD8+ and  CD8− γδ T cells was obtained by 
positive selection. Comparison of CTL activity showed 
unseparated mdPBMC contained the highest level of 
CTL activity followed by the cell preparations contain-
ing both CD4 and CD8 T cells and CD8 T cells. Minimal 
or no activity was observed with separated CD4 T cells 
or γδ T cells. NK cells were not evaluated for potential 
CTL activity in this study. Repeat studies showed they 
only comprised ~5% of cells present in mdPBMC stim-
ulated with Ag-pulsed bDC and MoDC. The results 
demonstrated the importance of the interaction of CD4 
and CD8 T cells in the generation of CTL. Further studies 
are needed to detail the signaling associated with interac-
tion of CD4 and CD8 T cells during Ag presentation.
Extensive studies conducted to elucidate the mecha-
nisms used by CTL to kill intracellular bacteria and 
protozoan parasites have shown perforin, GrzB, and 
granulysin play a role in killing [30, 45]. Our studies 
clearly show perforin and GrzB are involved in killing 
of Map. Further studies should show granulysin is also 
involved. An immune synapse develops on contact of 
CTL with the infected cells. Cytotoxic granules migrate 
to the synapse allowing perforin molecules to interca-
late into the membrane of the target cell and form pores 
through which granzymes and granulysin are introduced 
into the cytoplasm. Granulysin disrupts the integrity of 
the bacterial cell membrane allowing entrance of GrzB 
and death of the bacteria [30]. Analysis of effector cells 
after incubation with uninfected and infected MoMΦ 
showed CTL contact with infected MoMΦ is essential for 
killing. Newly synthesized perforin was present in CD8 
CTL incubated with infected MoMΦ. Only a few CD4 T 
cells contained newly synthesized perforin. In contrast, 
there was minimal or no increase in newly synthesized 
perforin in primed CD8 CTL incubated with uninfected 
MoMΦ. GrzB was detectable in half of the CD8 CTL 
with no detectable level in CD4 T cells. These results 
indicate the intracellular killing of Map is associated with 
upregulation of both perforin and GrzB, mainly in CD8 
CTL.
It has remained unclear as to whether apoptosis of the 
target cells, mediated by the perforin–granzyme pathway, 
is an essential component of the mechanisms of intracel-
lular killing of bacteria. Studies by Thoma-Uszynski et al. 
[37] have suggested killing of Mtb is independent of apop-
totic death of infected target cells. We conducted studies 
to examine this issue. Analysis of apoptosis showed the 
majority of infected MoMΦ were still viable after incuba-
tion with primed mdPBMC. The average percentages of 
apoptotic cells observed in infected MoMΦ co-cultured 
with Ag-primed mdPBMC was 13% compared to ~4% in 
infected MoMΦ co-cultured with control mdPBMC and 
~2% in uninfected MoMΦ co-cultured with Ag-primed 
mdPBMC. This is in contrast to CTL mediated killing of 
virus infected and cancer cells where apoptosis is clearly 
involved [46]. Introduction of GnzB leads to immedi-
ate initiation of apoptosis and death of the target cell. 
The majority of target cells infected with Map were still 
alive even after 3  days of incubation with Ag-primed 
mdPBMC. Further studies are needed to explain this 
apparent paradox. The interaction between Map and 
macrophages is a complex process affected by the lethal 
signals released by the CTL involved in the bacterial 
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killing and cell apoptosis. Further studies of the roles of 
apoptosis in defense against Map infection are needed 
to fully explain the results obtained by Thoma-Uszynski 
et al. [37] and the results obtained in the present study.
In summary, we have used the natural host to gain a 
better understanding of the immune response to Map 
and candidate vaccines. Data obtained thus far have 
shown relA plays a central role in the ability of Map to 
establish a persistent infection and that deletion of relA 
leads to immune elimination of the mutant. Ex  vivo 
analysis has shown MMP is a component of the immune 
response to ΔMap/relA. An equivalent CD8 CTL 
response is elicited with APC pulsed with ΔMap/relA or 
MMP. Simultaneous presentation of antigenic peptides to 
CD4 and CD8 by Ag pulsed bDC and MoDC is essential 
for generation of CTL. CTL activity is mediated through 
the perforin/granzyme pathway. In contrast to CTL 
activity against virus infected cells and cancer cells, intra-
cellular killing of bacteria occurs with limited induction 
of apoptosis. The assays developed to conduct the stud-
ies ex  vivo provide opportunities to study the potential 
efficacy of candidate vaccines as well as opportunities to 
study Ag presentation by DC and consequent prolifera-
tion and differentiation of CD4 and CD8 T cells with dif-
ferent functional activity.
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